It takes the average reader 4 hours and 30 minutes to read Methodological Challenges in Biomedical HIV Prevention Trials by Institute of Medicine
Assuming a reading speed of 250 words per minute. Learn more
The number of people infected with HIV or living with AIDS is increasing at unprecedented rates as various scientists, organizations, and institutions search for innovative solutions to combating and preventing the disease. At the request of the Bill & Melinda Gates Foundation, Methodological Challenges in Biomedical HIV Prevention Trials addresses methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials. This book recommends a number of ways to improve the design, monitoring, and analysis of late-stage clinical trials that evaluate nonvaccine biomedical interventions. The objectives include identifying a beneficial method of intervention, enhancing quantification of the impact, properly assessing the effects of using such an intervention, and reducing biases that can lead to false positive trial results. According to Methodological Challenges in Biomedical HIV Prevention Trials, the need to identify a range of effective, practical, and affordable preventive strategies is critical. Although a large number of promising new HIV prevention strategies and products are currently being tested in late-stage clinical trials, these trials face a myriad of methodological challenges that slow the pace of research and limit the ability to identify and fully evaluate effective biomedical interventions.
Methodological Challenges in Biomedical HIV Prevention Trials by Institute of Medicine is 270 pages long, and a total of 67,500 words.
This makes it 91% the length of the average book. It also has 82% more words than the average book.
The average oral reading speed is 183 words per minute. This means it takes 6 hours and 8 minutes to read Methodological Challenges in Biomedical HIV Prevention Trials aloud.
Methodological Challenges in Biomedical HIV Prevention Trials is suitable for students ages 12 and up.
Note that there may be other factors that effect this rating besides length that are not factored in on this page. This may include things like complex language or sensitive topics not suitable for students of certain ages.
When deciding what to show young students always use your best judgement and consult a professional.
Methodological Challenges in Biomedical HIV Prevention Trials by Institute of Medicine is sold by several retailers and bookshops. However, Read Time works with Amazon to provide an easier way to purchase books.
To buy Methodological Challenges in Biomedical HIV Prevention Trials by Institute of Medicine on Amazon click the button below.
Buy Methodological Challenges in Biomedical HIV Prevention Trials on Amazon